Industrifonden — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations.
Advanced ManufacturingBiotechDeep TechMedical DevicesNew MaterialsLong Beach, US
Maximilian Ottosson(Founder)inClint Monfort(Executive Officer, Director, Promoter)
Co-investorsEuropean Investment BankOnsight VenturesEICEuropean Innovation Council Fund
Open Payments is an API aggregator that connects financial institutions and businesses to multiple banks through a single unified API, supporting account information retrieval and payment initiation under the PSD2 directive.
Data & InfrastructureEnterprise SoftwareFintechStockholm, SE
Co-investorsGlobal BrainGoose Valley VenturesLuminar VenturesAlfvén & Didrikson
Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.
BiotechHealthtech
Ole Kaasbøll(Co-founder)
Co-investorsHealthCapLifeArc VenturesInvestinorNovo Holdings
Yangi produces complete dry-formed paper fiber machine lines and offers prototyping, lab services, and an industrial demo platform for packaging producers seeking plastic-free, fiber-based packaging.
Advanced ManufacturingCircular EconomyNew Materials
Zymego provides an automated appointment management system for healthcare providers that fills cancelled slots by notifying waiting patients and rebooking them within 90 seconds, integrating with EHR systems to reduce wait times, no-shows, and booking admin.
Digital HealthHealthtechSaaS
Co-investorsSpintop Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.